title: [Anti-rotavirus vaccination: what impedes its wide prescription].
abstract: The aim of this study was to analyze why anti-rotavirus vaccination is rarely used in France, although this infection is frequent and associated with a large number of hospitalizations.
  
  
  METHODS
  A questionnaire was sent to 732 general practitioners and pediatricians in the Bordeaux area.
  
  
  RESULTS
  The response rate was 57% (381 GPs and 38 pediatricians). Most of them (71.8%) declared that they received information on the vaccination and more than 80% of them feel that gastroenteritis is a severe disease. However, anti-rotavirus is never prescribed by the majority of them (59.6%) and only 2.6% prescribe it systematically. The reasons are that the patient is not refunded (64.2%), the vaccination timetable is overloaded (53.6%), and there are no recommendations for this vaccination (35.1%). Physicians believe that parents feel gastroenteritis as a benign disease (52.6%) and say that they refuse the vaccination because it is not refunded (77.7%), not mandatory (45.5%), or may have side effects (44.1%). Physicians' prescription of vaccination is correlated to their information on the vaccination and their feeling about the disease's severity. They would modify their practice if the vaccination was recommended and/or refunded.
  
  
  CONCLUSIONS
  The main obstacles against anti-rotavirus vaccination are the absence of recommendations and refunding. The recent recommendation for the vaccination and a lower price should lead to its generalization in France.
authors.affiliation: Unité de gastroentérologie et nutrition pédiatriques, hôpital des Enfants, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
authors.forename: A-L
authors.initials: AL
authors.lastname: Delteil
authors.affiliation: Unité de néonatologie, hôpital des Enfants, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
authors.forename: J
authors.initials: J
authors.lastname: Sarlangue
authors.affiliation: Unité de gastroentérologie et nutrition pédiatriques, hôpital des Enfants, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. Electronic address: thierry.lamireau@chu-bordeaux.fr.
authors.forename: T
authors.initials: T
authors.lastname: Lamireau
mesh_terms: D001291:Attitude of Health Personnel; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D003430:Cross-Sectional Studies; D003968:Diarrhea, Infantile / Q000191:economics / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D005260:Female; D005382:Financing, Personal / Q000191:economics; D005602:France; D005759:Gastroenteritis / Q000191:economics / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D058006:General Practice / Q000191:economics; D006306:Health Surveys; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D008297:Male; D010372:Pediatrics / Q000191:economics; D010818:Practice Patterns, Physicians'; D012051:Reimbursement Mechanisms / Q000191:economics; D012400:Rotavirus Infections / Q000191:economics / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000008:administration & dosage* / Q000191:economics / Q000276:immunology*; D011795:Surveys and Questionnaires
chemical_list: D022243:Rotavirus Vaccines